Clinical and immunoserological characteristics of mixed connective tissue disease associated with pulmonary arterial hypertension
- PMID: 16784493
- DOI: 10.1111/j.1365-3083.2006.01770.x
Clinical and immunoserological characteristics of mixed connective tissue disease associated with pulmonary arterial hypertension
Abstract
We investigated the clinical characteristics and immunoserological alterations in patients with mixed connective tissue disease (MCTD) associated with pulmonary arterial hypertension (PAH). Anti-U1RNP autoantibodies, anti-endothelial cell antibodies (AECA) and serum thrombomodulin (TM) as well as von Willebrand factor antigen (vWFAg) concentrations were measured in 25 patients with MCTD associated with PAH and in 154 MCTD patients without PAH. The results showed that the probability of survival was lower in MCTD patients with PAH than in the 154 MCTD-non-PAH patients (5-year survival rate in MCTD with PAH: 73%, versus 96% in MCTD-non-PAH; P < 0.01). AECA were more frequently present in the sera of MCTD patients with PAH than in MCTD-non-PAH (P < 0.001). Serum TM and vWFAg levels were higher in MCTD-PAH patients than in MCTD-non-PAH patients (TM: P < 0.001; vWFAg: P < 0.001). Significant correlation was noticed between the quantity of AECA and TM level (r = 0.466) as well as the quantity of AECA and vWFAg level (r = 0.550). In conclusion, our results suggest that in MCTD the presence of AECA and endothelial cell activation may play a role in the development of PAH and in the maintenance of obliterative vascular processes.
Similar articles
-
[A possible role of anti-endothelial cell antibody in the sera of MCTD patients on pulmonary vascular damage relating to pulmonary hypertension].Ryumachi. 2002 Dec;42(6):885-94. Ryumachi. 2002. PMID: 12632608 Japanese.
-
Immunological analysis of pulmonary hypertension in connective tissue diseases.J Rheumatol. 1999 Nov;26(11):2357-62. J Rheumatol. 1999. PMID: 10555891
-
The frequency of anti-beta2-glycoprotein I antibodies is low and these antibodies are associated with pulmonary hypertension in mixed connective tissue disease.Lupus. 2009 Jun;18(7):618-21. doi: 10.1177/0961203308101719. Lupus. 2009. PMID: 19433462
-
[Pulmonary arterial hypertension in connective tissue disease].Rev Mal Respir. 2006 Sep;23(4 Suppl):13S61-72. Rev Mal Respir. 2006. PMID: 17057632 Review. French.
-
The prognosis of mixed connective tissue disease.Rheum Dis Clin North Am. 2005 Aug;31(3):535-47, vii-viii. doi: 10.1016/j.rdc.2005.04.005. Rheum Dis Clin North Am. 2005. PMID: 16084324 Review.
Cited by
-
B-cells in pulmonary arterial hypertension: friend, foe or bystander?Eur Respir J. 2024 Apr 25;63(4):2301949. doi: 10.1183/13993003.01949-2023. Print 2024 Apr. Eur Respir J. 2024. PMID: 38485150 Free PMC article. Review.
-
Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.Int J Mol Sci. 2023 Feb 20;24(4):4178. doi: 10.3390/ijms24044178. Int J Mol Sci. 2023. PMID: 36835590 Free PMC article. Review.
-
Efficacy of bosentan in the treatment of a patient with mixed connective tissue disease complicated by pulmonary arterial hypertension.Clin Rheumatol. 2010 Jun;29(6):687-90. doi: 10.1007/s10067-009-1248-2. Epub 2009 Aug 4. Clin Rheumatol. 2010. PMID: 19653056
-
Increased levels of anti-heat-shock protein 60 (anti-Hsp60) indicate endothelial dysfunction, atherosclerosis and cardiovascular diseases in patients with mixed connective tissue disease.Immunol Res. 2014 Oct;60(1):50-9. doi: 10.1007/s12026-014-8552-x. Immunol Res. 2014. PMID: 24838263
-
Indispensable roles of OX40L-derived signal and epistatic genetic effect in immune-mediated pathogenesis of spontaneous pulmonary hypertension.BMC Immunol. 2011 Dec 15;12:67. doi: 10.1186/1471-2172-12-67. BMC Immunol. 2011. PMID: 22171643 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical